Five Prime Therapeutics Obtains $62,400,000 New Financing Round

  • Feed Type
  • Date
    9/18/2013
  • Company Name
    Five Prime Therapeutics
  • Mailing Address
    Two Corporate Dr South San Francisco, CA 94080
  • Company Description
    FivePrime (NASDAQ: FPRX) is a drug discovery and development company primarily focused on therapeutic proteins. The Company is creating a new paradigm in drug discovery by leveraging the Pharmanome(TM) – the entire set of pharmaceutically relevant genes and proteins.
  • Website
    http://www.fiveprime.com
  • Transaction Type
    IPO
  • Transaction Amount
    $62,400,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.